These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25295400)

  • 1. Individual treatment effects: implications for research, clinical practice, and policy.
    Graff JS; Grasela T; Meltzer DO; Dubois RW
    Am J Manag Care; 2014 Jul; 20(7):544-51. PubMed ID: 25295400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological recommendations for comparative research on the treatment of chronic wounds.
    Sonnad SS; Goldsack JC; Mohr P; Tunis S
    J Wound Care; 2013 Sep; 22(9):470-80. PubMed ID: 24005781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of comparative effectiveness research on health and health care spending.
    Basu A; Jena AB; Philipson TJ
    J Health Econ; 2011 Jul; 30(4):695-706. PubMed ID: 21696840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness research: policy and politics.
    Zusman EE
    Neurosurg Focus; 2012 Jul; 33(1):E6. PubMed ID: 22746238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health policy issues and applications for evidence-based medicine and clinical practice guidelines.
    Lohr KN; Eleazer K; Mauskopf J
    Health Policy; 1998 Oct; 46(1):1-19. PubMed ID: 10187652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in action: the role of passive personalization in comparative effectiveness research.
    Basu A; Jena AB; Goldman DP; Philipson TJ; Dubois R
    Health Econ; 2014 Mar; 23(3):359-73. PubMed ID: 24123568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.
    Trosman JR; Weldon CB; Schink JC; Gradishar WJ; Benson AB
    J Comp Eff Res; 2013 Jul; 2(4):461-77. PubMed ID: 24236686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking at CER from Medicare's perspective.
    Mohr P
    J Manag Care Pharm; 2012 May; 18(4 Suppl A):S5-8. PubMed ID: 22578211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economics of comparative effectiveness studies: societal and private perspectives and their implications for prioritizing public investments in comparative effectiveness research.
    Meltzer D; Basu A; Conti R
    Pharmacoeconomics; 2010; 28(10):843-53. PubMed ID: 20831292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.
    Ahmed S; Berzon RA; Revicki DA; Lenderking WR; Moinpour CM; Basch E; Reeve BB; Wu AW;
    Med Care; 2012 Dec; 50(12):1060-70. PubMed ID: 22922434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building academic health centers' capacity to shape and respond to comparative effectiveness research policy.
    VanLare JM; Conway PH; Rowe JW
    Acad Med; 2011 Jun; 86(6):689-94. PubMed ID: 21512371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An introduction to comparative effectiveness research.
    Marko NF; Weil RJ
    Neurosurgery; 2012 Feb; 70(2):425-34; discussion 434. PubMed ID: 21849923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.
    Oderda GM; Balfe LM
    J Manag Care Pharm; 2011; 17(9 Suppl B):S19-24. PubMed ID: 22073936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving state Medicaid policies with comparative effectiveness research: a key role for academic health centers.
    Zerzan JT; Gibson M; Libby AM
    Acad Med; 2011 Jun; 86(6):695-700. PubMed ID: 21512359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.